Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jonathan B. Edmiston"'
Autor:
Jonathan B. Edmiston, Elizabeth G. Cohn, Sergio L. Teruya, Natalia Sabogal, Daniel Massillon, Varsha Muralidhar, Carlos Rodriguez, Stephen Helmke, Denise Fine, Morgan Winburn, Codruta Chiuzan, Eldad A. Hod, Farbod Raiszadeh, Damien Kurian, Mathew S. Maurer, Frederick L. Ruberg
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Patients with heart failure (HF) often have multiple chronic conditions and are at increased risk for severe disease and mortality when infected by SARS-CoV-2, the virus that causes COVID-19. Furthermore, disparities in outcomes with COVID-19 have be
Externí odkaz:
https://doaj.org/article/b8cf5b941c0d4bfda9d0dd98213ea2a8
Autor:
Arianne Clare C. Agdamag, Jonathan B. Edmiston, Victoria Charpentier, Mohammed Chowdhury, Meg Fraser, Valmiki R. Maharaj, Gary S. Francis, Tamas Alexy
Publikováno v:
Medicina, Vol 56, Iss 12, p 678 (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) gained worldwide attention at the end of 2019 when it was identified to cause severe respiratory distress syndrome. While it primarily affects the respiratory system, we now have evidence t
Externí odkaz:
https://doaj.org/article/5cf41ad5e3ec4e4ca3362c5d7c59adce
Autor:
Elissa Driggin, Hannah Rosenblum, Sergio Teruya, Carlos Rodriguez, Damian Kurian, Farbod Raiszadeh, Denise Fine, Natalia Sabogal, Jonathan B Edmiston, Daniel Massillon, Morgan Winburn, Edward J Miller, Frederick Ruberg, Mathew Maurer
Publikováno v:
Journal of Cardiac Failure. 29:668-669
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2aeabd86f7058ad0bc5f22e95bfe206
https://doi.org/10.1016/j.cardfail.2022.10.299
https://doi.org/10.1016/j.cardfail.2022.10.299
Autor:
Jonathan B. Edmiston, Gary S. Francis, Tamas Alexy, Arianne Agdamag, V. Maharaj, Meg Fraser, Victoria Charpentier
Publikováno v:
Vessel Plus. 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ea17a676c6d40c25a09868669c550f3
https://doi.org/10.20517/2574-1209.2020.60
https://doi.org/10.20517/2574-1209.2020.60
Publikováno v:
CMAJ open, vol 6, iss 1
BACKGROUND:Despite the abundant research on financial conflict of interest regarding provider behaviour and the interpretation and results of research, little is known about the relation between these conflicts in academia and the trajectory of one's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21a99eb65b54263bee7c4178a16557c
https://doi.org/10.9778/cmajo.20170095
https://doi.org/10.9778/cmajo.20170095
Autor:
Cindy M. Martin, Victoria Charpentier, Andrew Shaffer, Arianne Agdamag, V. Maharaj, Rebecca Cogswell, Jessica Schultz, Sue Duval, Tamas Alexy, Ranjit John, Jonathan B. Edmiston, Gary S. Francis
Publikováno v:
Journal of Cardiac Failure. 26:S140-S141
Purpose Cardiopulmonary stress testing (CPX) is widely used to evaluate patients with end stage heart failure who may benefit from advanced therapies, such as durable left ventricular assist devices (LVAD). A hypotensive systolic blood pressure respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::423fde00f6d325562711d1edf93af5fb
https://doi.org/10.1016/j.cardfail.2020.09.407
https://doi.org/10.1016/j.cardfail.2020.09.407
Autor:
Arianne Agdamag, Ranjit John, Rebecca Cogswell, V. Maharaj, Jessica Schultz, Tamas Alexy, Cindy M. Martin, Andrew Shaffer, Jonathan B. Edmiston, Gary S. Francis, Victoria Charpentier, Sue Duval
Publikováno v:
Journal of Cardiac Failure. 26:S147-S148
Purpose Cardiopulmonary stress test (CPX) and right heart catheterization (RHC) are integral part of the routine evaluation for ventricular assist device (LVAD) therapy. A hypotensive response, or failure to augment systolic blood pressure at peak st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4a68c9c16b99f5e8f96c2ad3afaee6a
https://doi.org/10.1016/j.cardfail.2020.09.425
https://doi.org/10.1016/j.cardfail.2020.09.425
Autor:
Jonathan B. Edmiston, Arianne Agdamag, Gary S. Francis, Meg Fraser, Victoria Charpentier, Tamas Alexy, Mohammed Chowdhury, V. Maharaj
Publikováno v:
Medicina, Vol 56, Iss 678, p 678 (2020)
Medicina
Medicina
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) gained worldwide attention at the end of 2019 when it was identified to cause severe respiratory distress syndrome. While it primarily affects the respiratory system, we now have evidence t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93a867773f3ce57a8eecad249dcb6a2
https://doi.org/10.3390/medicina56120678
https://doi.org/10.3390/medicina56120678
Publikováno v:
Mayo Clinic Proceedings. 92:1164-1166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efdf8254f34fc928897fb4fdbdf5e44
https://doi.org/10.1016/j.mayocp.2017.04.014
https://doi.org/10.1016/j.mayocp.2017.04.014
Autor:
Hagai Tavori, Bart Duell, Szilard Voros, Michael D. Shapiro, Cezary Wojcik, Jonathan Q. Purnell, Jonathan B. Edmiston, Jessica Minnier, Nathan Brooks, Tina M. Kaufman, Sergio Fazio
Publikováno v:
Journal of clinical lipidology. 11(3)
Clinical trials testing proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have demonstrated an unanticipated but significant lipoprotein (a) (Lp(a))-lowering effect, on the order of 25% to 30%. Although the 50% to 60% reduction in low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dc56cfc020090ac047119e47eefd20d
https://pubmed.ncbi.nlm.nih.gov/28506388
https://pubmed.ncbi.nlm.nih.gov/28506388